RS
The startup develops a cardiovascular therapeutics platform focused on creating novel treatments for acute and chronic cardiovascular diseases, specifically targeting calcific aortic valve stenosis. By utilizing market access strategies, the company aims to enhance patient quality of life and delay the need for surgical valve replacement through non-invasive treatment options.
Updated 3 months ago
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a cardiovascular therapeutics platform focused on creating novel treatments for acute and chronic cardiovascular diseases, specifically targeting calcific aortic valve stenosis. By utilizing market access strategies, the company aims to enhance patient quality of life and delay the need for surgical valve replacement through non-invasive treatment options.